This protocol is judged by an institutional critique board, an independent group that opinions any scientific trials involving individuals. If a analyze includes a Plan I drug, after the board approves the protocol as ethical, the scientists should submit an application for an investigational new drug (IND) selection from the FDA.Thankfully, other